Zobrazeno 1 - 4
of 4
pro vyhledávání: ''
Autor:
D. J. Bevan, Bruce M. Hendry, Robert Higgins, A. N. Hillis, B S Carey, M. Bewick, Robert Vaughan, M. Fallon
Publikováno v:
Transplant International ISBN: 9783540610243
We are able to subdivide highly sensitised renal patients who wish to enter our immunoadsorption programme into two groups; those who will require acute pretransplant immunoadsorption only and those requiring regular immunoadsorption prior to transpl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec1f38e7200d333e6be85b03c4703e4f
https://doi.org/10.1007/978-3-662-00818-8_6
https://doi.org/10.1007/978-3-662-00818-8_6
Autor:
Y. Gothelf, S. Orgad, R. Gil, A. L. M. Watson, Ephraim Gazit, Edmond J. Yunis, Soo Young Yang, Theodore Pitman
Publikováno v:
Histocompatibility Testing 1984 ISBN: 9783642697722
Platelet-absorbed sera were obtained from placental clots after delivery by multiparous women. These sera contained antibodies that react with PHA-activated lymphocytes after the latter are separated from peripheral blood and expanded with interleuki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbebb5bd53185eaf76aa52f420737175
https://doi.org/10.1007/978-3-642-69770-8_156
https://doi.org/10.1007/978-3-642-69770-8_156
Autor:
Gustavo Rincon, Lynne Klingman, G.A. Teresi, C. McNamara, Robert W. Stewart, C. E. Pippenger, Andrea A. Zachary, William E. Braun
Publikováno v:
Immunobiology of HLA ISBN: 9783662389805
The presence of an autolymphocytotoxin (ALCT) in any potential organ recipient, and particularly cardiac recipients who often receive procainamide, can easily be confused with human leukocyte antigen (HLA) antibodies when serum screening and donor cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffd8fdeda58e10b616b9c915dcebdf41
https://doi.org/10.1007/978-3-662-39946-0_231
https://doi.org/10.1007/978-3-662-39946-0_231
Autor:
R. Storb
Publikováno v:
Modern Trends in Human Leukemia IV ISBN: 9783540106227
Marrow transplantation from a syngeneic (monozygous twin) or allogeneic [homologous leucocytic antibody (HLA)-identical sibling] donor allows the administration of aggressive antileukemic therapy without regard to marrow toxicity. Until 1975 marrow t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c555c0486a3654dad06def83f19c6a17
https://doi.org/10.1007/978-3-642-67984-1_20
https://doi.org/10.1007/978-3-642-67984-1_20